PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 134 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $26,000 | -70.1% | 13,419 | -30.4% | 0.00% | – |
Q4 2021 | $87,000 | -43.5% | 19,274 | -39.3% | 0.00% | -100.0% |
Q3 2021 | $154,000 | +27.3% | 31,745 | +37.2% | 0.00% | 0.0% |
Q2 2020 | $121,000 | -1.6% | 23,146 | +371.6% | 0.00% | 0.0% |
Q3 2017 | $123,000 | -8.9% | 4,908 | -43.8% | 0.00% | 0.0% |
Q4 2016 | $135,000 | +25.0% | 8,737 | +54.0% | 0.00% | 0.0% |
Q3 2015 | $108,000 | -91.2% | 5,674 | -82.2% | 0.00% | -83.3% |
Q4 2014 | $1,226,000 | – | 31,810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $13,340,000 | 9.89% |
Abingworth LLP | 1,041,131 | $5,341,000 | 4.85% |
Roumell Asset Management, LLC | 450,406 | $2,311,000 | 4.78% |
HIGHLAND CAPITAL MANAGEMENT LP | 2,391,993 | $12,271,000 | 0.94% |
Trellus Management Company, LLC | 71,200 | $365,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 1,968,000 | $10,096,000 | 0.76% |
Arbiter Partners Capital Management LLC | 1,111,936 | $5,704,000 | 0.64% |
Fortress Investment Group LLC | 433,804 | $2,226,000 | 0.27% |
GENERAL AMERICAN INVESTORS CO INC | 464,985 | $2,385,000 | 0.25% |
WATER ISLAND CAPITAL LLC | 318,518 | $1,634,000 | 0.12% |